Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Informing Clinical Decision and Policy Making in Blood Related Disorders Using Targeted Next Generation Sequencing

Betoul Baz, PhD, Tarek Owaidah, MDFRCPA, Majed Dasouki, MD, Mohammed Abouelhoda, PhD, Dorota Monies, PhD, Nada Al Tassan, PhD

Blood (2019) 134 (Supplement_1): 5776.

https://doi.org/10.1182/blood-2019-122370

Published: 2019

Journal Articles

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Flora Peyvandi, MD PhD, Paolo Bucciarelli, MD, Carla Valsecchi, BSc, Marco Boscarino, Roberta Palla, PhD, Elena Santagostino, Amal El-Beshlawy, Mohsen Saleh Elalfy, MD, Vijay M. Ramanan, MBBS,MDDM, Peyman Eshghi, MD, Suresh Hanagavadi, MD, Mehran Karimi, MD, Cecil Ross, MD, Mamta V Manglani, MD, Guy Young, Tulika Seth, MDMBBS,FAAP, Shashikant Apte, MD FRCPA, Dinesh M Nayak, MD, Maria Elisa Mancuso, Johnny Mahlangu, Bonanad Santiago, MD, Monica H Cerqueira, MD PhD, Nadia P Ewing, MD, Christoph Male, MD, Tarek Owaidah, MDFRCPA, Veronica Soto Arellano, MD, Suvankar Majumdar, MBCHB, Mindy Simpson, MD, Mathew Thomas, MD, Ezio Zanon, Marilyn J Manco-Johnson, MD, Monica Martinez, MD, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Rogelio Alejandro Paredes-Aguilera, MD, Alessandra N L Prezotti, MD MSc, Klaus Schmitt, MD, Bulent Zulfikar, Prof, Pier Mannuccio Mannucci, MD, Frits Richard Rosendaal, MD

Blood (2018) 132 (Supplement 1): 384.

https://doi.org/10.1182/blood-2018-99-114599

Published: 2018

Journal Articles

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Ayodele Alaiya, MPH, MBBS, PhD, Mahmoud Aljurf, MD, Zakia Shinwari, MSc, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP, Tarek Owaidah, MD FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Riad Elfakih, MD, Saud Alhayli, MD, Shahrukh Hashmi, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD

Blood (2018) 132 (Supplement 1): 5434.

https://doi.org/10.1182/blood-2018-99-118754

Published: 2018

Journal Articles

Development of Novel Nanobiosensor for Direct Measurement of the Oral Anticoagulant Agent: Dabigatran Etexilate

Maher M Al Johani, MBBS, Raja Chinnappana, PhD, Shimaa Eissaa, PhD, Tarek Owaidah, MDFRCPA, Dana Cialla-Mayc, PhD, Jürgen Poppc, PhD, Mohammed Zourob, PhD

Blood (2018) 132 (Supplement 1): 1247.

https://doi.org/10.1182/blood-2018-99-110689

Published: 2018

Journal Articles

Aautoimmune Hemolytic Anemia: Pattern of Clinical Presentation and Management Outcome — a Nine Year Observation from a Tertiary Care Hospital in Saudi Arabia

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Abdullah AlJefri, MD, Saba Parween, MBBS, Roula Barmada, MD, Silgy Jose, RN, Bouchra Safi, RN, Viqaruddin Mohammed, MSc, CCRP, Joumana AlEita, MD

Blood (2017) 130 (Supplement 1): 4744.

https://doi.org/10.1182/blood.V130.Suppl_1.4744.4744

Published: 2017

Journal Articles

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Hazzaa Alzahrani, MD, Tahani Bin Ali, MD, Huda ElFaraidi, MD, Mahmoud Abu Riash, RN, Zikra Alkhayal, MD, AbdulKareem Al Momen, MD, Viqaruddin Mohammed, MSc, CCRP, Azzah AlZahrani, MD

Blood (2017) 130 (Supplement 1): 5587.

https://doi.org/10.1182/blood.V130.Suppl_1.5587.5587

Published: 2017

Journal Articles

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

Ayodele Alaiya, MBBS,MPH,PhDFRCPath, Zakia Shinwari, MSc, Hazza Alzahrani, MD, Tarek Owaidah, MD, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Randa M Alnounou, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Raid El Fakih, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Abdulaziz Alfraih, MD, Hashmi Shahrukh, MD, Majed Dasouki, MD, Naeem A. Chaudhri, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Mahmoud Aljurf

Blood (2017) 130 (Supplement 1): 2465.

https://doi.org/10.1182/blood.V130.Suppl_1.2465.2465

Published: 2017

Journal Articles

First Report from the Saudi Bleeding Screening Study: Are Platelet Disorders More Common in Arabs?

Tarek Owaidah, MD FRCPA, Abdul Kareem M Al-Momen, MD FRCPC, Hazza A Alzahrani, MD, Abdulmajeed Albanyan, Ayman Alsulaiman, Siddiqui Khawar, ALI Alzahrani, MD, Mohammad al-Madani, Khalid AlSaleh, MBBS, FRCPC, MRCP, Saleh Mahsin

Blood (2015) 126 (23): 4641.

https://doi.org/10.1182/blood.V126.23.4641.4641

Published: 2015

Journal Articles

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Flora Peyvandi, MD PhD, Pier Mannuccio Mannucci, MD, Isabella Garagiola, PhD, Mohsen Elalfy, MD, Amal El-Beshlawy, MD, Madatha V. Ramanan, MD, Peyman Eshghi, MD, Suresh Hanagavadi, Ramabadran Varadarajan, MD, Mehran Karimi, MD, Mamta V. Manglani, MD, Cecil Ross, MD, Guy Young, MD, Tulika Seth, MD, Shashikant Apte, MD FRCPA, Dinesh M. Nayak, MD, Adriana C. Sandoval Gonzales, MD, Elena Santagostino, MD PhD, Maria Elisa Mancuso, MD PhD, Johnny N. Mahlangu, MD, Santiago Bonanad, PhD, Monica Cerqueira, MD, Nadia P. Ewing, MD, Christoph Male, MD MSC, Tarek Owaidah, MD FRCPA, Veronica Soto Arellano, MD, Nathan L. Kobrinsky, MD FRCP, Suvankar Majumdar, MD, Rosario Perez Garrido, MD, Anupam Sachdeva, Mindy Simpson, MD FAAP, Mathew Thomas, Ezio Zanon, MD, ALI Bulent Antmen, Kaan Kavakli, MD, Marilyn Manco-Johnson, MD, Monica Martinez, MD, Esperanza Marzouka, MS, PS, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Angeles Palomo Bravo, MD, Rogelio Paredes Aguilera, MD, Alessandra Nunes Loureiro Prezotti, MD, Schmitt Klaus, MD, Brian M. Wicklund, MD MPH, Bulent Zulfikar, MD, Rosendaal R. Frits, MD PhD

Blood (2015) 126 (23): 5.

https://doi.org/10.1182/blood.V126.23.5.5

Published: 2015

Journal Articles

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

Ayodele Alaiya, MPH,MBBS,PhD FRCPath, Hazza A Alzahrani, MD, Zakia Shinwari, MSc, Tarek Owaidah, MD FRCPA, Fahad Al Mohareb, MD, Fahad Al Sharif, MD, Randa Al Nounou, MD, Naeem A. Chaudhri, MD FACP, Ghuzayel Aldawsari, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Alfraih, MD, Syed Osman Ahmed, MD MRCP, FRCPath, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 2414.

https://doi.org/10.1182/blood.V126.23.2414.2414

Published: 2015

Journal Articles

Proteomics–Based Approach Predicts Molecular Response and Stratifies Responders to Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) Patients

Ayodele Alaiya, MD MPH, PhD, Naeem A. Chaudhri, MD FACP, Hafiz Malhan, MD, Tarek Owaidah, MD FRCPA, Zakia Shinwari, MSc, Jonathan Fox, PhD, Fahad Alsharif, MD, Said Mohamed, MD, Walid Rasheed, MD, Osman Ahmed Syed, MD FRCPA, Mahmoud D. Aljurf, MD

Blood (2014) 124 (21): 4556.

https://doi.org/10.1182/blood.V124.21.4556.4556

Published: 2014

Journal Articles

Rare Inherited Clotting Factor Deficiencies in Paediatric Population Single Tertiary Centre Experience in Saudi Arabia

Mahasen al Saleh, Tarek Owaidah, MD FRCPA, Abdulrahman Al Musa, Hazzaa Al-Zahrani, MBBS,MRCP, Suleman Al-Sweedan, Nicy Joseph, Rubina Malik, Khawar Siddiqui, MSc, Sohaib Zulfiqar, Rafat Jafri

Blood (2014) 124 (21): 5064.

https://doi.org/10.1182/blood.V124.21.5064.5064

Published: 2014

Journal Articles

Expression Proteomics As Surrogate Biomarkers For Early Treatment Response In Chronic Myeloid Leukemia (CML) Patients

Ayodele Alaiya, MD, MPH, PhD, Naeem Chaudhri, MD, Tarek Owaidah, MD, FRCPA, Jonathan Fox, PhD, Zakia Shinwari, MSc, Eman Barhoush, BSc, Fahad Alsharif, MD, Said Y Mohamed, MD, Walid Rasheed, M.D., Feras Alfraih, MD, Mahmoud Aljurf, M.D.

Blood (2013) 122 (21): 4016.

https://doi.org/10.1182/blood.V122.21.4016.4016

Published: 2013

Journal Articles

CD64 Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Maher Albitar, M.D., Amal Alseraihy, M.D., Mouhab Ayas, Abdullah Al-Jefri, M.D., Ali Al-Ahmari, MD, Asim F Belgaumi, MD, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hassan El-Solh, MD

Blood (2011) 118 (21): 3525.

https://doi.org/10.1182/blood.V118.21.3525.3525

Published: 2011

Journal Articles

CD34 Expression in Adult Acute Lymphoblastic Leukemia (ALL) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant in First Remission,

Mahmoud Aljurf, M.D., Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4091.

https://doi.org/10.1182/blood.V118.21.4091.4091

Published: 2011

Journal Articles

CD11b Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Blood (2011) 118 (21): 4092.

https://doi.org/10.1182/blood.V118.21.4092.4092

Published: 2011

Journal Articles

Noval Mutation in Four Saudi Families with Glanzmann Thrombasthenia

Tarek Owaidah, MD, FRCPA, Hala Abalkhail, PhD, Abdulrahman Al Musa, Hasan Mosmali, Albanyan Abdulmajeed, Abdullah Al Jefri, MD, Randa alNounou, Hazzaa Al Zahrani, Mahasen Saleh, MD

Blood (2011) 118 (21): 1136.

https://doi.org/10.1182/blood.V118.21.1136.1136

Published: 2011

Journal Articles

Lack of CD34 Expression in Acute Myeloid Leukemia (AML) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant Irrespective of the Cytogenetic Risk

Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 1894.

https://doi.org/10.1182/blood.V118.21.1894.1894

Published: 2011

Journal Articles

CEBPA Single Nucleotide Polymorphism (SNP) rs34529039 As An Independent Adverse Prognostic Factor in Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Mahmoud Aljurf, M.D., Hala Abalkhail, PhD, Tarek Owaidah, MD, FRCPA, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Claudia Ulrike Walter, PhD, Mohammed Toulimat, MT, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 1465.

https://doi.org/10.1182/blood.V118.21.1465.1465

Published: 2011

Journal Articles

Expression of CD56 in Acute Myeloid Leukemia (AML) Is Associated with Poor Outcome When Patients Treated with Stem Cell Transplant in Second Remission but Not in the First Remission

Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4880.

https://doi.org/10.1182/blood.V118.21.4880.4880

Published: 2011

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Informing Clinical Decision and Policy Making in Blood Related Disorders Using Targeted Next Generation Sequencing

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Development of Novel Nanobiosensor for Direct Measurement of the Oral Anticoagulant Agent: Dabigatran Etexilate

Aautoimmune Hemolytic Anemia: Pattern of Clinical Presentation and Management Outcome — a Nine Year Observation from a Tertiary Care Hospital in Saudi Arabia

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

First Report from the Saudi Bleeding Screening Study: Are Platelet Disorders More Common in Arabs?

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

Proteomics–Based Approach Predicts Molecular Response and Stratifies Responders to Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) Patients

Rare Inherited Clotting Factor Deficiencies in Paediatric Population Single Tertiary Centre Experience in Saudi Arabia

Expression Proteomics As Surrogate Biomarkers For Early Treatment Response In Chronic Myeloid Leukemia (CML) Patients

CD64 Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

CD34 Expression in Adult Acute Lymphoblastic Leukemia (ALL) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant in First Remission,

CD11b Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Noval Mutation in Four Saudi Families with Glanzmann Thrombasthenia

Lack of CD34 Expression in Acute Myeloid Leukemia (AML) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant Irrespective of the Cytogenetic Risk

CEBPA Single Nucleotide Polymorphism (SNP) rs34529039 As An Independent Adverse Prognostic Factor in Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Expression of CD56 in Acute Myeloid Leukemia (AML) Is Associated with Poor Outcome When Patients Treated with Stem Cell Transplant in Second Remission but Not in the First Remission

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only